Eye Patient Adherence and Compliance Study
Key facts
- Where
- Hamilton, CanadaSee the site
Where in Canada
- St Joseph's Regional Eye ClinicHamilton, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- St. Joseph's Healthcare Hamilton
- Trial code
- NCT07793474
- Record updated
- 28 August 2026
- Original description
This study looks at ways to help people with glaucoma take their eye drops regularly and attend their clinic appointments. Each participant will be asked about the main challenges they face, such as forgetfulness, difficulty using drops, lack of transportation, or limited understanding of their condition. Based on their biggest challenge, participants will receive one type of support that is already part of usual care, such as education, reminders, help with applying drops, or assistance getting to appointments. The investigators will follow participants over time to see if this support improves how well they follow their treatment and their quality of life.Read full original descriptionShow less
Eye Patient Adherence and Compliance Study-Intervention Program (EYE-PACIP): Improving Glaucoma Adherence and Compliance in High-risk Patients With a Multi-interventional Program
This study looks at ways to help people with glaucoma take their eye drops regularly and attend their clinic appointments. Each participant will be asked about the main challenges they face, such as forgetfulness, difficulty using drops, lack of transportation, or limited understanding of their condition. Based on their biggest challenge, participants will receive one type of support that is already part of usual care, such as education, reminders, help with applying drops, or assistance getting to appointments. The investigators will follow participants over time to see if this support improves how well they follow their treatment and their quality of life.
Exclusion: Significant cognitive impairment, neurodegenerative disease, or severe psychiatric illness limiting participation or understanding of the intervention; Participants will be excluded if they meet any of the following criteria:; Participation in another interventional study targeting glaucoma adherence or follow-up; Anticipated inability to complete 12-month follow-up (e.g., planned relocation or transfer of care outside the study catchment area).
Participants will be eligible for inclusion if they meet all of the following criteria:; Adults aged 18 years and older; Clinical diagnosis of glaucoma or ocular hypertension confirmed by an ophthalmologist; Currently prescribed at least one topical intraocular pressure (IOP)-lowering medication; Identified as high risk for non-adherence and/or poor follow-up, defined by one or more of the following:; Self-reported or documented missed ≥20% of prescribed eye drops; Missed two or more glaucoma clinic appointments; Evidence of structural or functional glaucoma progression (e.g., OCT or visual field deterioration); Willing to participate in study interventions and follow-up assessments Able to communicate in the study language.